Yosipovitch, G. .; Zeidler, C. .; Apfelbacher, C. J. .; Laquer, V. .; Kim, B. S. .; Casillas, M. .; Pierce, E. .; Chen, S. .; Qiao, M. .; Agell, H. .; Del Rosso, J. . Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year. J of Skin 2023, 7, s273.